The influence of highly immunogenic Rhesus or Kell alloantibodies on the association between the FCGR2C.nc-ORF polymorphism and alloimmunization
| . | OR . | CI . | P . | N (control/cases) . |
|---|---|---|---|---|
| Controls vs alloimmunized cases, cases, exclusively Rh or K antibodies* | ||||
| FCGR2C.nc-ORF | 0.50 | 0.14-1.81 | .292 | 130/40 |
| Controls vs alloimmunized cases, cases, at least 1 antibody other than Rh or K | ||||
| FCGR2C.nc-ORF | 0.19 | 0.06-0.59 | .004 | 130/102 |
| . | OR . | CI . | P . | N (control/cases) . |
|---|---|---|---|---|
| Controls vs alloimmunized cases, cases, exclusively Rh or K antibodies* | ||||
| FCGR2C.nc-ORF | 0.50 | 0.14-1.81 | .292 | 130/40 |
| Controls vs alloimmunized cases, cases, at least 1 antibody other than Rh or K | ||||
| FCGR2C.nc-ORF | 0.19 | 0.06-0.59 | .004 | 130/102 |
Entry in boldface type indicates a significant value.
RhD, C, c, E, e, or K antibodies.